BRPI0714672B8 - derivados de camptotecina, composição farmacêutica contendo os mesmos e seu uso - Google Patents

derivados de camptotecina, composição farmacêutica contendo os mesmos e seu uso

Info

Publication number
BRPI0714672B8
BRPI0714672B8 BRPI0714672A BRPI0714672A BRPI0714672B8 BR PI0714672 B8 BRPI0714672 B8 BR PI0714672B8 BR PI0714672 A BRPI0714672 A BR PI0714672A BR PI0714672 A BRPI0714672 A BR PI0714672A BR PI0714672 B8 BRPI0714672 B8 BR PI0714672B8
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
camptothecin derivatives
composition containing
derivatives
preparation
Prior art date
Application number
BRPI0714672A
Other languages
English (en)
Inventor
Battaglia Arturo
Samori Cristian
Manzotti Carla
Fontana Gabriele
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of BRPI0714672A2 publication Critical patent/BRPI0714672A2/pt
Publication of BRPI0714672B1 publication Critical patent/BRPI0714672B1/pt
Publication of BRPI0714672B8 publication Critical patent/BRPI0714672B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)

Abstract

derivados de camptotecina, processo para preparação, composição farmacêutica e uso dos referidos derivados. a presente invenção refere-se a derivados de camptotecina tendo atividade antitumor, processos para a preparação dos mesmos, uso dos mesmos como fármacos antitumor e composições farmacêuticas contendo os mesmos.
BRPI0714672A 2006-07-26 2007-07-16 derivados de camptotecina, composição farmacêutica contendo os mesmos e seu uso BRPI0714672B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2006A001474 2006-07-26
IT001474A ITMI20061474A1 (it) 2006-07-26 2006-07-26 Derivati della camptotecina ad attivita antitumorale
PCT/EP2007/006294 WO2008012003A1 (en) 2006-07-26 2007-07-16 Camptothecin derivatives with antitumor activity

Publications (3)

Publication Number Publication Date
BRPI0714672A2 BRPI0714672A2 (pt) 2013-03-26
BRPI0714672B1 BRPI0714672B1 (pt) 2020-10-20
BRPI0714672B8 true BRPI0714672B8 (pt) 2021-05-25

Family

ID=38668855

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0714672A BRPI0714672B8 (pt) 2006-07-26 2007-07-16 derivados de camptotecina, composição farmacêutica contendo os mesmos e seu uso

Country Status (20)

Country Link
US (1) US8193210B2 (pt)
EP (1) EP2044080B1 (pt)
JP (1) JP5313895B2 (pt)
KR (1) KR101496374B1 (pt)
CN (1) CN101495485B (pt)
AU (1) AU2007278509B2 (pt)
BR (1) BRPI0714672B8 (pt)
CA (1) CA2658902C (pt)
DK (1) DK2044080T3 (pt)
ES (1) ES2628022T3 (pt)
HK (1) HK1135692A1 (pt)
IL (1) IL196652A0 (pt)
IT (1) ITMI20061474A1 (pt)
MX (1) MX2009000828A (pt)
NO (1) NO342506B1 (pt)
PL (1) PL2044080T3 (pt)
PT (1) PT2044080T (pt)
RU (1) RU2450007C2 (pt)
SI (1) SI2044080T1 (pt)
WO (1) WO2008012003A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9379559B2 (en) 2012-02-03 2016-06-28 International Business Machines Corporation System and method of charging a vehicle using a dynamic power grid, and system and method of managing power consumption in the vehicle
PL235836B1 (pl) * 2012-10-25 2020-11-02 Inst Chemii Organicznej Polskiej Akademii Nauk Pochodne kamptotecyny, sposób ich otrzymywania i zastosowanie
CN108690036B (zh) * 2018-05-22 2021-05-25 北京海步医药科技股份有限公司 一种10-二氟甲基喜树碱类化合物及其制备方法和应用
LU102067B1 (en) 2020-09-17 2022-03-18 Narodowy Inst Lekow 7-Ethyl-10-hydroxycamptothecin derivatives for use in the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972955A (en) * 1995-06-06 1999-10-26 Dr. Reddy's Research Foundation Water soluble C-ring analogues of 20(S)-camptothecin
IT1282673B1 (it) * 1996-02-23 1998-03-31 Ist Naz Stud Cura Dei Tumori Derivati della camptotecina e loro uso come agenti antitumorali

Also Published As

Publication number Publication date
AU2007278509A1 (en) 2008-01-31
JP2010500971A (ja) 2010-01-14
KR20090032100A (ko) 2009-03-31
CA2658902C (en) 2014-09-23
EP2044080B1 (en) 2017-05-10
RU2009102241A (ru) 2010-07-27
WO2008012003A1 (en) 2008-01-31
CA2658902A1 (en) 2008-01-31
EP2044080A1 (en) 2009-04-08
AU2007278509B2 (en) 2012-10-04
ES2628022T3 (es) 2017-08-01
CN101495485B (zh) 2012-04-11
DK2044080T3 (en) 2017-07-17
US8193210B2 (en) 2012-06-05
US20100010032A1 (en) 2010-01-14
CN101495485A (zh) 2009-07-29
SI2044080T1 (sl) 2017-07-31
NO342506B1 (no) 2018-06-04
IL196652A0 (en) 2009-11-18
NO20090252L (no) 2009-01-16
RU2450007C2 (ru) 2012-05-10
BRPI0714672A2 (pt) 2013-03-26
MX2009000828A (es) 2009-02-03
PL2044080T3 (pl) 2017-10-31
PT2044080T (pt) 2017-06-15
KR101496374B1 (ko) 2015-03-04
HK1135692A1 (en) 2010-06-11
BRPI0714672B1 (pt) 2020-10-20
JP5313895B2 (ja) 2013-10-09
ITMI20061474A1 (it) 2008-01-27

Similar Documents

Publication Publication Date Title
BRPI0714553B8 (pt) derivados de camptotecina, processo para preparação dos mesmos, composição farmacêutica e seu uso
BRPI0513901A (pt) derivados de uréia cìclicos substituìdos, preparação dos mesmos e uso farmacêutico dos mesmos como inibidores de cinase
BRPI0720972B8 (pt) compostos análogos de ciclopamina e composições farmacêuticas compreendendo os referidos compostos
BRPI0712631A8 (pt) compostos, processos para a preparação de um composto, composição farmacêutica, uso de um composto e combinações
UY32648A (es) Nuevos derivados de pirimidina y su uso en el tratamiento de enfermedades
BRPI0714803B8 (pt) compostos peptidomiméticos de smac, seus usos, e composição farmacêutica
BRPI0514731A (pt) derivados de pirimidina
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
BRPI0707302B8 (pt) compostos de cianoisoquinolina que atuam no dano tecidual associado com isquemia, hipóxia e anemia, bem como composição farmacêutica que os compreende
BRPI0610850A2 (pt) derivados de Ácido aril alquila, composiÇço farmacÊutica, medicamento, bem como uso dos referidos derivados
BRPI0509912A (pt) compostos, processo para a preparação dos mesmos, composição farmacêutica, e, uso de um composto
BRPI0910832B8 (pt) derivados de tienopiridona como ativadores de proteína quinase ativada por amp (ampk), seus usos, seu processo de preparação e seus intermediários, e medicamentos.
AR047928A1 (es) Derivados de tetrahidropiridoindol
BRPI0507198A (pt) derivados de bisariluréia
BRPI0613859A8 (pt) compostos derivados de nitrocatecol, seu uso e seu processo de preparação, bem como composição farmacêutica
BRPI0707704A8 (pt) derivados de antranilamida / 2-amino-heteroareno carboxamida
BR112012011793A2 (pt) "acrilamidas heterocíclicas e seu uso como farmacêuticos"
BRPI0806863B8 (pt) uso de um éster de forbol na preparação de um medicamento para prevenção ou tratamento de uma infecção por hiv
UY30215A1 (es) Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones
BRPI0616111B8 (pt) derivados de carboxamida, composição farmacêutica, uso dos mesmos e combinação
BRPI0815547B8 (pt) composição farmacêutica compreendendo depsipeptídeos cíclicos, e seus usos
BR112012012261A2 (pt) compostos como moduladores de receptor com utilidade terapêutica
BR112014018795A2 (pt) derivados de 1h-pirrolo[2,3-b]piridina e seu uso como inibidores de cinase
BR112012009310B8 (pt) composto derivados de 2-oxo-1-pirrolidinil imidazotiadiazol, uso dos mesmos e composição farmacêutica compreendendo os mesmos
BR112015024971A2 (pt) derivados de n-(2,3-di-hidro-1h-pirrolo[2,3-b]piridin-5-il)-4-quinazolinamina e n-(2,3-di-hidro-1h-indol-5-il)-4-quinazolinamina como inibidores de perk

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 20/10/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/07/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 15A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2679 DE 10-05-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.